Boston Scientific (WBO:BSXC) Change In Receivables

: €-220 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

Boston Scientific's change in receivables for the quarter that ended in Dec. 2023 was €-68 Mil. It means Boston Scientific's Accounts Receivable increased by €68 Mil from Sep. 2023 to Dec. 2023 .

Boston Scientific's change in receivables for the fiscal year that ended in Dec. 2023 was €-218 Mil. It means Boston Scientific's Accounts Receivable increased by €218 Mil from Dec. 2022 to Dec. 2023 .

Boston Scientific's Accounts Receivable for the quarter that ended in Dec. 2023 was €2,043 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Boston Scientific's Days Sales Outstanding for the three months ended in Dec. 2023 was 54.58.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Boston Scientific's liquidation value for the three months ended in Dec. 2023 was €-10,846 Mil.

Boston Scientific Change In Receivables Historical Data

The historical data trend for Boston Scientific's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-117.00

275.37

-246.92

-207.68

-218.25

Boston Scientific Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables																-41.54	-80.32	-69.23	-2.81	-67.86

Boston Scientific Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-220 Mil.

Boston Scientific (WBO:BSXC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Boston Scientific's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2043.076	/	3415.825	*	91
=	54.58

2. In Ben Graham's calculation of liquidation value, Boston Scientific's accounts receivable are only considered to be worth 75% of book value:

Boston Scientific's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	793.205	-	14310.702	+	0.75 * 2043.076	+	0.5 * 2277.828
=	-10,846

Boston Scientific Change In Receivables Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Boston Scientific (WBO:BSXC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (WBO:BSXC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BSX:USA BSX:Mexico 1BSX:Italy BSX:Germany B1SX34:Brazil

Address

300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234

Website

https://www.bostonscientific.com

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (WBO:BSXC) Headlines

No Headlines